Beta Bionics, Inc. 8-K

What Happened
On April 21, 2026, Beta Bionics, Inc. announced its financial results for the quarter ended March 31, 2026 by issuing a press release. The company reported this information in a Form 8-K under Item 2.02 (Results of Operations and Financial Condition); the press release is attached to the filing as Exhibit 99.1. The filing was signed by Sean Saint, President and Chief Executive Officer.

Key Details

• Filing date: April 21, 2026 (Form 8-K submitted under Item 2.02).
• Reporting period: Quarter ended March 31, 2026 (Q1 2026 quarterly results).
• Disclosure vehicle: Press release attached as Exhibit 99.1 to the Form 8-K.
• Signature: Form 8-K signed by Sean Saint, President and Chief Executive Officer.

Why It Matters
Quarterly results provide updated information on Beta Bionics' earnings, revenue trends, and financial condition that can affect investor decisions and share price. This Form 8-K formally notifies the market that the company has released Q1 2026 results; investors should review the attached press release (Exhibit 99.1) for the full financial figures, operational highlights, and any management commentary.